Medscape focuses on compounders

As the fallout (and questions) of the official end to the tirzepatide shortage continues, news outlets are continuing to turn to APC for compounders’ perspective. Medscape is the latest, and it quotes CEO Scott Brunner extensively.

Since the FDA announced that tirzepatide is (for now) out of shortage, APC’s Scott Brunner has been...

Chemical and Engineering News looked at the question of “How will FDA changes reshape drug approval...

Patients in the Dallas area are feeling the sticker shock of the end of the GLP-1 shortages. APC's...

Medscape focuses on compounders

Related posts

Commenting on the tirzepatide announcement

Even niche media recognizes APC

Scott helps North Texas understand the new GLP-1 landscape